Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.
Cellares has raised $257.0M in total funding. The most recent round was Series D. The last funding was announced in January 2026.
Cellares's investors include 8VC, BlackRock, Eclipse Ventures, Intuitive Ventures, EcoR1 Capital.
Cellares is headquartered in South San Francisco, United States.
Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.
Cellares is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellares — Funding & Investors." VCBacked, January 28, 2026, https://www.vcbacked.co/company/cellares. Accessed July 20, 2026.
VCBacked. (2026). Cellares — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cellares
{{cite web |title=Cellares — Funding & Investors |url=https://www.vcbacked.co/company/cellares |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated